Episode

Veeva Systems ($VEEV): Platform Expansion vs. CRM Competition in a Mission-Critical SaaS

Podcast
Stock Spotlight
Published
Feb 4, 2026
Duration seconds
2250
Processing state
not_requested
Canonical source
https://podcasters.spotify.com/pod/show/mf369/episodes/Veeva-Systems-VEEV-Platform-Expansion-vs--CRM-Competition-in-a-Mission-Critical-SaaS-e3ednbb
Audio
https://anchor.fm/s/fa8f9bac/podcast/play/114793259/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-0-30%2F01f976e6-30e0-d27e-1baf-32d304262ad7.mp3
JSON
/v1/public/podcasts/stock-spotlight-7027390/episodes/veeva-systems-veev-platform-expansion-vs-crm-competition-in-a-mission-critical-saas
Markdown
/podcast/stock-spotlight-7027390/veeva-systems-veev-platform-expansion-vs-crm-competition-in-a-mission-critical-saas.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/stock-spotlight-7027390/episodes/veeva-systems-veev-platform-expansion-vs-crm-competition-in-a-mission-critical-saas/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/stock-spotlight-7027390/veeva-systems-veev-platform-expansion-vs-crm-competition-in-a-mission-critical-saas.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode of Stock Spotlight, Michael dives deep into Veeva Systems, the vertically integrated SaaS platform powering critical workflows across the life sciences industry. From clinical trials and regulatory compliance to commercial CRM and embedded data analytics, Veeva has become the operating system for biopharma, delivering elite margins, strong free cash flow per share and a wide economic moat built on high switching costs and regulated environments. Michael explore Veeva’s growth drivers, including rapid expansion in R&D solutions, emerging AI-powered workflows and long-term optionality within a $20B+ TAM, while also addressing the key risks facing the stock today: increasing CRM competition from Salesforce and the ultimate long-term impact of AI. Using a quality-focused fundamental framework combined with valuation and technical analysis, I break down why Veeva remains a high-quality compounder, what metrics investors should monitor and whether the current setup presents an attractive long-term opportunity. ---------------------------------------------------------------- 00:00 Intro 00:38 Investment Checklist & Database 01:17 Business Overview 09:22 Industry Overview 14:41 Quality Growth Profile 17:55 Financial Statement Overview 22:47 Leadership & Incentives 28:15 KPIs to Track 29:26 Valuation & Technical Analysis 33:49 Verdict 36:54 Outro ---------------------------------------------------------------- Intro Music: Andrey Rossi – Seize the Day Outro Music: Ra – Prospect *Music provided by Uppbeat Premium Follow me on X: ⁠ https://x.com/invest091⁠ Subscribe to my YouTube channel: https://www.youtube.com/@stockspotlightpodcast ---------------------------------------------------------------- Disclosure: The host of Stock Spotlight is not a l…